Aspergillus pulmonary infections in transplant recipients.
Aspergillus infections are increasing in frequency in those undergoing solid organ and hematopoietic stem cell transplantation. The ongoing impact of Aspergillus infection on morbidity and mortality after transplantation makes this subject an area of intense clinical and research interest. This article discusses the evolving epidemiologic features of the infection and its management and diagnosis.
White
Dorothy A
DA
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA. whited@mskcc.org
D001228:Aspergillosis / Q000209:etiology* / Q000382:microbiology; D001230:Aspergillus / Q000302:isolation & purification*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D008172:Lung Diseases, Fungal / Q000209:etiology* / Q000382:microbiology; D016377:Organ Transplantation / Q000009:adverse effects*